分享 收藏

Recombinant Human GDF-5/BMP-14

品牌：翌圣生物
產(chǎn)地：
供應(yīng)商報(bào)價(jià)：面議

翌圣生物科技(上海)股份有限公司更新時(shí)間：2024-12-24 09:03:45

銷售范圍售全國

入駐年限第1年

營業(yè)執(zhí)照已審核

同類產(chǎn)品GDF-5BMP-14(2件)

立即掃碼咨詢

聯(lián)系方式：400-611-1883

聯(lián)系我們時(shí)請說明在儀器網(wǎng)（www.vietnamtrade.org）上看到的!

掃碼分享

為您推薦

Mouse GDF-5/BMP-14

詳細(xì)介紹

Growth Differentiation Factor-5 (GDF-5; also called BMP-14 and CDMP-1) is a member of the BMP family of TGF-beta superfamily proteins. Human GDF-5, -6, and -7 are a defined subgroup of the BMP family. GDF-5 is synthesized as a homodimeric precursor protein consisting of a 354 amino acid (aa) N-terminal pro-region and a 120 aa C-terminal mature peptide. Mature human GDF-5 shares 99% aa sequence identity with both mature mouse and rat GDF-5. GDF-5 signaling is mediated by formation of a heterodimeric complex consisting of a type 1 (BMPR-IB) and a type II (BMPR-II or Activin RII) serine/threonine kinase receptor which results in the phosphorylation and activation of cytosolic Smad proteins (Smad1, 5, and 8). Similar to other BMP family proteins, GDF-5 signaling is antagonized by Noggin. GDF-5 is involved in multiple developmental processes including limb generation, cartilage development, joint formation, bone morphogenesis, cell survival, and neuritogenesis.

Product Properties

Synonyms	CDMP-1, CDMP1LAP4
Accession	P43026
GeneID	8200
Source	E.coli-derived Human GDF-5/BMP-14, Ala382-Arg501.
Molecular Weight	Approximately 27.1 kDa.
AA Sequence	APLATRQGKR PSKNLKARCS RKALHVNFKD MGWDDWIIAP LEYEAFHCEG LCEFPLRSHL EPTNHAVIQT LMNSMDPEST PPTCCVPTRL SPISILFIDS ANNVVYKQYE DMVVESCGCR
Tag	None
Physical Appearance	Sterile Filtered White lyophilized (freeze-dried) powder.
Purity	> 95% by SDS-PAGE and HPLC analyses.
Biological Activity	The ED₅₀ as determined by inducing alkaline phosphatase production of murine ATDC5 cells is less than 1.0 μg/mL, corresponding to a specific activity of > 1000 IU/mg. Fully biologically active when compared to standard.
Endotoxin	< 0.1 EU per 1μg of the protein by the LAL method.
Formulation	Lyophilized from a 0.2 µm filtered concentrated solution in 30% Acetonitrile and 0.1% TFA.
Reconstitution	We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in 4 mM HCl to a concentration of 0.1-1.5 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20℃. Further dilutions should be made in appropriate buffered solutions.